In a new guest post on the Amazon Web Services (AWS) Blog, our Executive Director Erika Vial Monteverdi highlights how we apply AWS. Cancer Commons learns from the experiences and outcomes of all patients we serve. This process requires sophisticated computing and analysis of large datasets, and AWS is an integral component of our system: Read the post.
“We need to break down the barriers between health institutions to allow patients and their trusted clinicians to access global data about individual patient treatment decisions and outcomes.” … A new article written by lymphoma patient Brad Power outlines why the underlying philosophy that drives our work here at Cancer Commons is so important for ensuring that patients receive the care they need. Brad… Read more »
By 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. Our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, led this research, which was presented at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. These projections, prepared in collaboration with MD Anderson Cancer Center… Read more »
Around the world, physicians are seeking better treatments for COVID-19. What can they learn from cancer research? Today, STAT published an article written by Cancer Commons founder Marty Tenenbaum, PhD, in which he outlines how our strategy to learn from cancer patients who are trying treatments beyond the standard of care could also be applied to the coronavirus pandemic: “This same rapid-learning approach can… Read more »
Erika Vial Monteverdi, Executive Director of Cancer CommonsCancer Commons is a patient-centric, nonprofit network of patients, physicians, and scientists that helps identify the best options for treating an individual’s cancer. Here, our Curious Dr. George asks executive director Erika Vial Monteverdi what sets Cancer Commons apart. Q: As the Executive Director of Cancer Commons, how do you consider our approach to be uniquely different from that of many other organizations working… Read more »
Lola Rahib, PhD (left), and Conan Kinsey, MD, PhD (right), present our findings in San Diego, CAToday, our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, presented initial findings from our real-world data registry on a novel treatment combination for pancreatic cancer patients. Performed in collaboration with xCures and the University of Utah’s Huntsman Cancer Institute, this research was presented at the Special Conference on Advancing Precision Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies, hosted… Read more »
In a new Q&A with the Precision Medicine World Conference, Executive Director Erika Vial Monteverdi outlines how Cancer Commons is helping people navigate their treatment, and shares her vision for the future: “We are trying to help advanced cancer patients get practical ‘shots on goal’ against their cancer AND learn from the massive number of therapies tried with patients.” Click here for the full Q&A.… Read more »
Cancer Commons has partnered with the Precision Medicine World Conference to organize a dedicated Patient Track at their meeting in Silicon Valley, CA, in January 2020. We’ve lined up a great group of people to speak on a variety of topics about putting patient needs first, and understanding and accessing the latest cancer treatment options. Patients, caregivers, and advocates are welcome to attend, and can… Read more »
Last week, Cancer Commons founder Marty Tenenbaum, PhD, shared our mission and impact at a fundraiser gala hosted by the Kids & Art Foundation in Palo Alto, CA. The theme of the night? “Technology. Research. Therapy. Conversations on improving quality of cancer care.” Marty, who founded Cancer Commons after his own cancer journey, joined other innovative leaders at the gala to discuss the hopeful progress being… Read more »
In this month’s issue of Gentry Magazine, executive director Erika Vial Monteverdi shares the incredible impact that Cancer Commons has had for patients, as well as our bold and unique vision for the future: “At the core, it’s a very simple idea: namely, to wrap research and care around patient needs first. This starts with understanding a patient’s diagnosis, giving them compassion through good… Read more »